EA201270749A1 - Композиции с вирусным ингибитором для терапевтического применения in vivo, включающие сочетание (-)-карвона, (+) карвона, гераниола и дополнительного эфиромасличного компонента - Google Patents

Композиции с вирусным ингибитором для терапевтического применения in vivo, включающие сочетание (-)-карвона, (+) карвона, гераниола и дополнительного эфиромасличного компонента

Info

Publication number
EA201270749A1
EA201270749A1 EA201270749A EA201270749A EA201270749A1 EA 201270749 A1 EA201270749 A1 EA 201270749A1 EA 201270749 A EA201270749 A EA 201270749A EA 201270749 A EA201270749 A EA 201270749A EA 201270749 A1 EA201270749 A1 EA 201270749A1
Authority
EA
Eurasian Patent Office
Prior art keywords
carvon
geraniol
combination
essential oil
vivo
Prior art date
Application number
EA201270749A
Other languages
English (en)
Other versions
EA025278B1 (ru
EA025278B9 (ru
Inventor
Кристин Коппен
Original Assignee
Сеса Альянс С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42102951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201270749(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Сеса Альянс С.А. filed Critical Сеса Альянс С.А.
Publication of EA201270749A1 publication Critical patent/EA201270749A1/ru
Publication of EA025278B1 publication Critical patent/EA025278B1/ru
Publication of EA025278B9 publication Critical patent/EA025278B9/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Настоящее изобретение относится к антивирусной композиции, включающей следующие компоненты: R-(-)-2-метил-5-(проп-1-ен-2-ил)-циклогекс-2-енон (также именуемый (-)-карвоном) и S-(+)-2-метил-5-(проп-1-ен-2-ил)-циклогекс-2-енон (также именуемый (+)-карвоном), и (2Е)-3,7-диметилоктан-2,6-диен-1-ол (также именуемый транс-гераниолом) в сочетании по меньшей мере с еще одним компонентом, избранным из эфиромасличных компонентов для применения в лечении и профилактике расстройств, вызванных вирусами с ДНК и заключенными в оболочку, вирусами с ДНК и не заключенными в оболочку, вирусами с РНК и заключенными в оболочку, вирусами с РНК и не заключенными в оболочку.
EA201270749A 2010-03-26 2011-03-28 Антивирусная композиция против заключенных или незаключенных в оболочку днк- или рнк-вирусов EA025278B9 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10157930A EP2368547B1 (en) 2010-03-26 2010-03-26 Antiviral compositions comprising geraniol and carvone
PCT/EP2011/054758 WO2011117424A1 (en) 2010-03-26 2011-03-28 Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-) -carvone, geraniol and a further essential oil component

Publications (3)

Publication Number Publication Date
EA201270749A1 true EA201270749A1 (ru) 2013-03-29
EA025278B1 EA025278B1 (ru) 2016-12-30
EA025278B9 EA025278B9 (ru) 2017-03-31

Family

ID=42102951

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270749A EA025278B9 (ru) 2010-03-26 2011-03-28 Антивирусная композиция против заключенных или незаключенных в оболочку днк- или рнк-вирусов

Country Status (35)

Country Link
US (2) US8980945B2 (ru)
EP (2) EP2368547B1 (ru)
JP (1) JP5342085B2 (ru)
KR (1) KR101340260B1 (ru)
CN (1) CN102946876B (ru)
AU (1) AU2011231511B2 (ru)
BR (1) BR112012024260B1 (ru)
CA (1) CA2790087C (ru)
CL (1) CL2012002606A1 (ru)
CO (1) CO6602166A2 (ru)
CY (3) CY1113449T1 (ru)
DK (2) DK2368547T3 (ru)
EA (1) EA025278B9 (ru)
ES (2) ES2392938T3 (ru)
HK (1) HK1176019A1 (ru)
HR (2) HRP20120964T1 (ru)
HU (1) HUE026121T2 (ru)
IL (1) IL222048A (ru)
LU (1) LU91805B1 (ru)
MA (1) MA34074B1 (ru)
ME (1) ME02035B (ru)
MX (1) MX346412B (ru)
MY (2) MY153104A (ru)
NZ (1) NZ602602A (ru)
PE (2) PE20130065A1 (ru)
PL (2) PL2368547T3 (ru)
PT (2) PT2368547E (ru)
RS (2) RS52544B (ru)
SG (1) SG184039A1 (ru)
SI (2) SI2368547T1 (ru)
SM (2) SMT201200062B (ru)
TN (2) TN2012000444A1 (ru)
UA (1) UA102497C2 (ru)
WO (1) WO2011117424A1 (ru)
ZA (2) ZA201208116B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2707950C1 (ru) * 2018-11-28 2019-12-02 Общество с ограниченной ответственностью "ЭРБИ" Средство для обработки среды пребывания птицы на основе липосом с фитокомпозицией с иммунотропным действием и избирательным антисептическим эффектом и способ его применения

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103998011B (zh) 2011-11-03 2016-11-23 荷兰联合利华有限公司 个人清洁组合物
MX354483B (es) 2011-12-06 2018-03-07 Unilever Nv Composición antimicrobiana.
BR112014013601B1 (pt) 2011-12-06 2020-04-14 Unilever Nv composições antimicrobianas, método não terapêutico para desinfetar uma superfície e usos não terapêuticos de uma composição
WO2013083583A1 (en) 2011-12-06 2013-06-13 Unilever N.V. Antimicrobial composition
MX347951B (es) * 2012-06-27 2017-05-19 Unilever Nv Composicion antimicrobiana.
RU2533254C2 (ru) * 2012-12-29 2014-11-20 Федеральное государственное бюджетное учреждение научно-исследовательский институт детских инфекций Федерального медико-биологического агентства Способ лечения неврологических осложнений при ветряной оспе у детей
TWI463979B (zh) * 2013-04-12 2014-12-11 Nat Defense Medical Ct 檸檬醛用於製備治療局部腎絲球硬化症之藥物的用途
KR20150145314A (ko) 2014-06-18 2015-12-30 원광대학교산학협력단 카르본을 유효성분으로 포함하는 항균 조성물
CN106727628A (zh) * 2016-12-17 2017-05-31 郑州郑先医药科技有限公司 一种治疗慢性腹泻的西药组合物
KR101970281B1 (ko) * 2017-07-28 2019-04-18 고려대학교 산학협력단 리나릴 아세테이트를 포함하는 올메사탄으로 유발된 장운동과다증의 예방 또는 치료용 조성물
CN107648488A (zh) * 2017-09-29 2018-02-02 陈晓阳 一种用于治疗慢性咽炎的丸剂
KR102118181B1 (ko) * 2018-06-12 2020-06-02 광주여자대학교 산학협력단 식물성 정유를 유효성분으로 포함하는 a형 인플루엔자 바이러스에 대한 항바이러스 조성물
US20200179299A1 (en) * 2018-12-07 2020-06-11 Global Biolife Inc. Composition and method of controlling infectious diseases with functional fragrances
CN110496117B (zh) * 2019-09-30 2022-09-06 中国科学院微生物研究所 一种小分子化合物在抗非洲猪瘟病毒感染中的新应用
CN111012769B (zh) * 2019-12-05 2021-02-12 青海大学 一种用于治疗包虫病的药物组合物、药物制剂及乳剂制备方法
WO2021224947A1 (en) * 2020-05-02 2021-11-11 Norouzi Mehdi Formulation of acute respiratory disease control formulation
CN114716327A (zh) * 2020-12-14 2022-07-08 中南民族大学 柏木醇衍生物、其制备方法及其应用
CA3102947A1 (en) * 2020-12-18 2022-06-18 Skymount Medical Us Inc. Nutraceuticals useful in the treatment of coronavirus diseases
JP7133820B1 (ja) * 2021-06-09 2022-09-09 塩野香料株式会社 コロナウイルス感染症予防用香料組成物及び結合阻害剤
CN113994963B (zh) * 2021-09-26 2023-04-28 中国农业科学院烟草研究所(中国烟草总公司青州烟草研究所) 一种含有乙酸二氢香芹酯的抑芽剂及其用途
TWI800937B (zh) * 2021-10-01 2023-05-01 奇美醫療財團法人奇美醫院 用於治療登革熱病毒感染之方法
CN117338758B (zh) * 2023-12-06 2024-03-12 北京远大九和药业有限公司 一种药物组合物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5667M (ru) 1966-03-10 1968-01-02
LU78955A1 (de) * 1978-01-27 1979-09-06 Chimicasa Gmbh Verfahren zur inaktivierung von viren
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
AU2002217316A1 (en) * 2001-01-03 2002-07-30 Medpharma Plc Use of terpenes for the treatment of digestive tract infections
US20040071757A1 (en) * 2001-11-20 2004-04-15 David Rolf Inhalation antiviral patch
EP1954130B1 (en) * 2005-11-30 2018-06-13 Eden Research Plc Methods comprising terpene mixtures comprising thymol and citral
EP2125171A4 (en) * 2007-01-10 2012-05-16 Univ Michigan ULTRAFILTRATION MEMBRANE, DEVICE, BIOARTIFICIAL ORGAN AND CORRESPONDING METHOD
KR100796312B1 (ko) * 2007-05-23 2008-01-21 주식회사 바이오미스트테크놀로지 게라니얼，네랄 및 유게놀을 유효성분으로 함유하는 동물용소독제 조성물
KR100950428B1 (ko) 2008-06-05 2010-04-02 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 디아릴헵타노이드계 화합물
KR100941595B1 (ko) 2008-06-05 2010-02-11 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 트리테르페노이드계 화합물

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2707950C1 (ru) * 2018-11-28 2019-12-02 Общество с ограниченной ответственностью "ЭРБИ" Средство для обработки среды пребывания птицы на основе липосом с фитокомпозицией с иммунотропным действием и избирательным антисептическим эффектом и способ его применения

Also Published As

Publication number Publication date
EA025278B1 (ru) 2016-12-30
CO6602166A2 (es) 2013-01-18
US8980945B2 (en) 2015-03-17
AU2011231511B2 (en) 2014-03-20
DK2555763T3 (da) 2014-08-04
PE20141008A1 (es) 2014-09-20
PE20130065A1 (es) 2013-03-08
LU91805B1 (fr) 2011-09-26
NZ602602A (en) 2012-12-21
KR101340260B1 (ko) 2013-12-10
CA2790087C (en) 2013-07-30
CY1113449T1 (el) 2016-06-22
SI2368547T1 (sl) 2013-01-31
RS53435B (en) 2014-12-31
EA025278B9 (ru) 2017-03-31
CN102946876A (zh) 2013-02-27
CA2790087A1 (en) 2011-09-29
PT2555763E (pt) 2014-08-04
MY153104A (en) 2014-12-31
KR20120128716A (ko) 2012-11-27
RS52544B (en) 2013-04-30
CL2012002606A1 (es) 2013-10-18
HRP20140706T1 (hr) 2014-09-12
JP2013523622A (ja) 2013-06-17
SI2555763T1 (sl) 2014-08-29
WO2011117424A1 (en) 2011-09-29
AU2011231511A1 (en) 2012-10-18
PL2555763T3 (pl) 2014-09-30
TN2012000444A1 (en) 2014-01-30
ZA201208116B (en) 2014-04-30
SG184039A1 (en) 2012-10-30
MX346412B (es) 2017-03-17
BR112012024260A2 (pt) 2016-07-12
ES2486765T3 (es) 2014-08-19
ME02035B (me) 2013-04-30
SMT201400104B (it) 2014-09-08
US20130225676A1 (en) 2013-08-29
IL222048A (en) 2014-09-30
MX2012010949A (es) 2013-01-29
TN2013000366A1 (en) 2015-01-20
SMT201200062B (it) 2013-03-08
EP2555763B1 (en) 2014-04-30
HRP20120964T1 (en) 2012-12-31
HUE026121T2 (en) 2016-05-30
CN102946876B (zh) 2016-04-06
EP2368547A1 (en) 2011-09-28
PT2368547E (pt) 2012-11-20
EP2368547B1 (en) 2012-09-12
HK1176019A1 (en) 2013-07-19
CY1119841T1 (el) 2018-06-27
MY158757A (en) 2016-11-15
EP2555763A1 (en) 2013-02-13
UA102497C2 (ru) 2013-07-10
MA34074B1 (fr) 2013-03-05
CY1115375T1 (el) 2017-01-04
ES2392938T3 (es) 2012-12-17
BR112012024260B1 (pt) 2019-12-31
PL2368547T3 (pl) 2013-02-28
US8883859B1 (en) 2014-11-11
DK2368547T3 (da) 2013-01-02
ZA201306926B (en) 2014-04-30
JP5342085B2 (ja) 2013-11-13

Similar Documents

Publication Publication Date Title
EA201270749A1 (ru) Композиции с вирусным ингибитором для терапевтического применения in vivo, включающие сочетание (-)-карвона, (+) карвона, гераниола и дополнительного эфиромасличного компонента
EA201490854A1 (ru) Противовирусные соединения
EA200971074A1 (ru) Антивирусные соединения
EA201790781A3 (ru) Противовирусные соединения
EA201890333A1 (ru) Противовирусные соединения
MD20140112A2 (ru) Аналоги 2'-замещенных карба-нуклеозидов для противовирусного лечения
EA201490132A1 (ru) Противовирусные соединения
EA201491179A1 (ru) 2',4'-дифтор-2'-метил замещенные нуклеозидные производные в качестве ингибиторов репликации рнк вируса гепатита с
EA201390155A1 (ru) Комбинации ингибиторов вируса гепатита с
EA201791744A2 (ru) Улучшенная липидная композиция
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA201492002A1 (ru) Противовирусные соединения
BR112015000161A2 (pt) composições de vetor de vírus adeno-associado modificado
GEP20156313B (en) Substituted nucleotide analogs
BR112015007879A2 (pt) inibidores do vírus da hepatite c
EA201071367A1 (ru) Соли соединений ингибиторов вич
EA201590790A1 (ru) СТАБИЛЬНАЯ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ОСНОВЕ PEG-ИНТЕРФЕРОНА АЛЬФА-2b
EA200602049A1 (ru) Пролекарства стероидов с андрогенным действием
TH131426B (th) องค์ประกอบสารยับยั้งไวรัส (Viral inhibitor composition) สำหรับการใช้รักษา โรคภายในสิ่งมีชีวิตที่ประกอบด้วยการรวมของ (-)-คาร์โวน, (+)-คาร์โวน (Carvone), เจรานิออล (Geraniol) และ ส่วนประกอบน้ำมันที่จำเป็นนอกจากนี้

Legal Events

Date Code Title Description
TH4A Publication of the corrected specification to eurasian patent